3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
65
Neoplasms
50
Colorectal Neoplasms
49
Prostatic Neoplasms
39
Carcinoma, Non-Small-Cell Lung
39
Lung Neoplasms
34
Pancreatic Neoplasms
27
Leukemia, Myeloid, Acute
23
Multiple Myeloma
21
Recurrence
17
Carcinoma, Hepatocellular
17
Uterine Cervical Neoplasms
16
Ovarian Neoplasms
15
Neoplasm Metastasis
14
Squamous Cell Carcinoma of Head and Neck
13
Head and Neck Neoplasms
13
Triple Negative Breast Neoplasms
12
Stomach Neoplasms
12
Melanoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Glioblastoma
11
Endometrial Neoplasms
11
Rectal Neoplasms
10
Carcinoma, Renal Cell
10
Brain Neoplasms
10
Advanced Solid Tumors
10
Lymphoma, B-Cell
9
Disease
9
Colonic Neoplasms
9
Esophageal Neoplasms
8
Interventions
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Monoclonal Gammopathy of Undetermined Significance
×
30 days
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled